Financial Year |
March 31 2023 |
Monetary Funds |
277,333,444.90 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
11,523,533.68 |
Accounts Receivable |
70,151,652.56 |
Advances to Suppliers |
22,314,136.30 |
Other Receivables |
5,256,379.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
109,418,052.91 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
5,773,352.23 |
Total Current Assets |
675,653,722.12 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
79,198,237.92 |
Investment Properties |
-- |
Fixed Assetes |
174,057,076.22 |
Under-construction Projects |
2,717,085.73 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
10,025,642.18 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
5,267,074.52 |
Other Non-Current Assets |
296,373.71 |
Sub-Total of Non-Current Assets |
272,934,932.44 |
Total Assets |
948,588,654.56 |
Short-Term Loans |
14,950,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
13,968,292.16 |
Accounts Payable |
37,058,371.95 |
Accounts Received In Advance |
16,064.00 |
Employee Compensation Payable |
2,368,876.17 |
Taxes Payable |
1,341,226.77 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
7,247,853.59 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
915,640.54 |
Other Current Liabilities |
1,523,772.81 |
Sub-Total of Current Liabilities |
80,608,910.55 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,220,100.19 |
Total Liabilities |
81,829,010.74 |
Paid-In Capital(Or Share Stock) |
612,000,000.00 |
Capital Surplus |
174,991,325.75 |
Surplus Reserve |
53,516,220.11 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
25,174,112.32 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
866,759,643.82 |
Owner's Equity(Stockholder's Equity) |
866,759,643.82 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
948,588,654.56 |